Filter Type: All Time (1 Results) Past 24 Hours Past Week Past month Post Your Comments?
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmaco-dynamics and preliminary anti-tumor activity of DRP-104 (sirpiglenastat) administered via intravenous infusion or via subcutaneous injection as a single agent and in combination with atezolizumab in patients with advanced solid tumors and to …
Preview / Show more
Updated: 5 hours ago
See Also:Lpu Drp Contact Number, Single Pebble Phone Number, Show details
All Time (1 Results) Past 24 Hours Past Week Past month